Product and process for transformation of thraustochytriales microorganisms
View Patent ↗Disclosed are nucleic acid and amino acid sequences for acetolactate synthase, acetolactate synthase regulatory regions, α-tubulin promoter, a promoter from a Thraustochytriales polyketide synthase (PKS) system, and fatty acid desaturase promoter, each from a Thraustochytriales microorganism. Also disclosed are recombinant vectors useful for transformation of Thraustochytriales microorganisms, as well as a method of transformation of Thraustochytriales microorganisms. The recombinant nucleic acid molecules of the present invention can be used for the expression of foreign nucleic acids in a Thraustochytriales microorganism as well as for the deletion, mutation, or inactivation of genes in Thraustochytriales microorganisms.
1. An isolated nucleic acid molecule comprising a nucleic acid sequence selected from the group consisting of:
(a) a nucleic acid sequence encoding a protein having an amino acid sequence that is at least 90% identical to an amino acid sequence selected from the group consisting of SEQ ID NO:15, SEQ ID NO:19, SEQ ID NO:22 and SEQ ID NO:24, wherein the protein is an acetolactate synthase; and
(b) a nucleic acid sequence that is a full complement to the nucleic acid sequence of (a).
2. The isolated nucleic acid molecule of claim 1 , wherein expression of the protein of (a) confers reduced sensitivity to compounds selected from the group consisting of: sulfonylurea compounds, imidazolinone-class inhibitors, and pyrimidinyl oxybenzoates, onto a microorganism of the Order Thraustochytriales that is transformed with the nucleic acid molecule.
3. The isolated nucleic acid molecule of claim 1 , wherein the nucleic acid sequence encodes a Schizochytrium acetolactate synthase.
4. The isolated nucleic acid molecule of claim 1 , wherein the nucleic acid encodes a Schizochytrium acetolactate synthase, and expression of the Schizochytrium acetolactate synthase confers reduced sensitivity to compounds selected from the group consisting of: sulfonylurea compounds, imidazolinone-class inhibitors, and pyrimidinyl oxybenzoates, onto a microorganism of the Order Thraustochytriales that is transformed with the nucleic acid molecule.
5. A recombinant nucleic acid molecule comprising the isolated nucleic acid molecule of claim 1 , operatively linked to a transcription control sequence.
6. The recombinant nucleic acid molecule of claim 5 , wherein the transcription control sequence is selected from the group consisting of a Thraustochytriales α-tubulin promoter, a Thraustochytriales acetolactate synthase promoter, a promoter from a Thraustochytriales polyketide synthase (PKS) system, and a Thraustochytriales fatty acid desaturase promoter.
7. The recombinant nucleic acid molecule of claim 6 , wherein the Thraustochytriales acetolactate synthase promoter comprises nucleotides 1-1259 of SEQ ID NO:14.
8. The recombinant nucleic acid molecule of claim 6 , wherein the Thraustochytriales α-tubulin promoter comprises nucleotides 441-894 of SEQ ID NO:9.
9. The recombinant nucleic acid molecule of claim 5 , further comprising a signal sequence.
10. A recombinant microorganism of the order Thraustochytriales that is transformed with the recombinant nucleic acid molecule of claim 5 .
11. A recombinant vector comprising the isolated nucleic acid molecule of claim 1 .
12. The recombinant vector of claim 11 , wherein the recombinant vector is an expression vector.
13. The recombinant vector of claim 11 , wherein the recombinant vector is a targeting vector.
14. The recombinant vector of claim 11 , further comprising a selectable marker.
15. The recombinant vector of claim 14 , wherein the selectable marker is a nucleic acid sequence encoding a bleomycin-binding protein.
16. A recombinant vector for transformation of a microorganism of the Order Thraustochytriales, comprising a nucleic acid sequence encoding an acetolactate synthase that confers reduced sensitivity to compounds selected from the group consisting of: sulfonylurea compounds, imidazolinone-class inhibitors, and pyrimidinyl oxybenzoates, onto the microorganism of the order Thraustochytriales, wherein said acetolactate synthase has an amino acid sequence that is at least 90% identical to an amino acid sequence selected from the group consisting of SEQ ID NO:15, SEQ ID NO:19, SEQ ID NO:22 and SEQ ID NO:24; wherein the nucleic acid sequence encoding an acetolactate synthase is operatively linked to a transcription control sequence.
17. The recombinant vector of claim 16 , wherein the transcription control sequence is selected from the group consisting of a Thraustochytriales α-tubulin promoter, a Thraustochytriales acetolactate synthase promoter, a promoter from a Thraustochytriales polyketide synthase (PKS) system, and a Thraustochytriales fatty acid desaturase promoter.
18. The recombinant vector of claim 17 , wherein the Thraustochytriales acetolactate synthase promoter comprises nucleotides 1-1259 of SEQ ID NO:14.
19. The recombinant vector of claim 17 , wherein the α-tubulin promoter comprises nucleotides 441-894 of SEQ ID NO:9.
20. The recombinant nucleic acid molecule of claim 16 , further comprising a signal sequence.
21. The recombinant vector of claim 16 , wherein the recombinant vector is an expression vector.
22. The recombinant vector of claim 16 , wherein the recombinant vector is a targeting vector.
23. The recombinant vector of claim 16 , further comprising a selectable marker.
24. The recombinant vector of claim 23 , wherein the selectable marker is a nucleic acid sequence encoding a bleomycin-binding protein.